Quizartinib

73 interactions 4 explained in plain English

Also sold as: Vanflyta

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ketoconazole Topical Irinotecan Injection Goserelin Implant Felbamate Dofetilide Oxaliplatin Injection

1 Contraindicated 71 Major 1 Moderate

All (73) Contraindicated (1) Major (71) Moderate (1)

Contraindicated

Quizartinib Ketoconazole Topical Extina® Foam Increased CYP3A4 substrate exposure and an increased risk of QT interval prolongation Details

Major

Quizartinib Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Quizartinib Sertraline Explained An increased risk of QT interval prolongation Details Quizartinib Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Quizartinib Simvastatin Flolipid Explained Increased BCRP substrate exposure and an increased risk of BCRP substrate-related adverse reactions Details Quizartinib Alpelisib Piqray Increased BCRP substrate exposure and an increased risk of BCRP substrate-related adverse reactions Details Quizartinib Amisulpride Injection Barhemsys An increased risk of QT interval prolongation Details Quizartinib Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Quizartinib Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Quizartinib Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Quizartinib Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Quizartinib Atovaquone Mepron An increased risk of QT interval prolongation Details Quizartinib Azithromycin AzaSite An increased risk of QT interval prolongation Details Quizartinib Alfuzosin UroXatral An increased risk of QT interval prolongation Details Quizartinib Anagrelide Agrylin An increased risk of QT interval prolongation Details Quizartinib Bedaquiline Sirturo An increased risk of QT interval prolongation Details Quizartinib Chloroquine Aralen® An increased risk of QT interval prolongation Details Quizartinib Dasatinib Phyrago An increased risk of QT interval prolongation Details Quizartinib Degarelix Injection Firmagon An increased risk of QT interval prolongation Details Quizartinib Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Quizartinib Disopyramide Norpace An increased risk of QT interval prolongation Details Quizartinib Dofetilide Tikosyn An increased risk of QT interval prolongation Details Quizartinib Dolasetron Anzemet An increased risk of QT interval prolongation Details Quizartinib Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Quizartinib Doxycycline Injection Acticlate An increased risk of QT interval prolongation Details Quizartinib Encorafenib Braftovi Reduced quizartinib exposure, reduced the efficacy of quizartinib and an increased risk of QT interval prolongation Details Quizartinib Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Quizartinib Eribulin Injection Halaven An increased risk of QT interval prolongation Details Quizartinib Famotidine Calmicid An increased risk of QT interval prolongation Details Quizartinib Famotidine Injection Calmicid An increased risk of QT interval prolongation Details Quizartinib Felbamate Felbatol An increased risk of QT interval prolongation Details Quizartinib Flecainide Tambocor® An increased risk of QT interval prolongation Details Quizartinib Foscarnet Injection Foscavir An increased risk of QT interval prolongation Details Quizartinib Galantamine Razadyne An increased risk of QT interval prolongation Details Quizartinib Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Quizartinib Gemifloxacin Factive An increased risk of QT interval prolongation Details Quizartinib Glasdegib Daurismo An increased risk of QT interval prolongation Details Quizartinib Goserelin Implant Zoladex An increased risk of QT interval prolongation Details Quizartinib Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Quizartinib Granisetron Injection Granisol An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.